Amy Page

Dr. Amy Page is a Senior Lecturer in Pharmacy at the University of Western Australia's School of Allied Health and the inaugural Director of the Centre for Optimisation of Medicines. Her research focuses on deprescribing, quality use of medicines in geriatrics, and reducing polypharmacy-related harm in older adults. She has received over $13M in funding, published 160+ articles, and led influential projects like the Opti-med trial and development of the MATCH-D framework.

Education & Qualifications:

• PhD (2017)
• MClinPharm (Clinical Pharmacy)
• GradDipBiostat (Biostatistics)
• GradCertDMEd (Diabetes Management Education)
• GradCertHProfEd (Health Professional Education)

Research Interests: Dr. Page's work addresses medication optimization for older adults, with a focus on deprescribing strategies, polypharmacy reduction, and improving medication safety in aged care settings. She also develops clinical guidelines and educational programs for pharmacists.

Key Achievements:

• Recipient of Australian Pharmacist of the Year (2024) and Young Pharmacist of the Year (2015)
• 2022 Vice-Chancellor’s Early Career Research Award
• Lead developer of national standards for pharmacist prescribing and aged care medication management
• Course Director for Doctor of Pharmacy Practice and Advanced Clinical Practice programs

Grants & Impact: Over $13M in funding secured, leading projects such as the Centre of Research Excellence in Medicines and Ageing (CREMA) and the Safe Recovery initiative reducing hospital falls. Her work has influenced national policies like the APC accreditation standards and international frameworks like the Global Competency Framework.

Teaching & Leadership: Oversees pharmacy postgraduate programs and pioneered microcredentials in clinical skills, prescribing, and diabetes education. Served as State President of the Pharmaceutical Society of Australia and on the Pharmacy Board of Australia.